Research any topic before you write.

Find related topics. | Discover entities. | See connections. | Build a topical map.

Biogen

Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the treatment of neurological diseases. The company's primary products are dimethyl fumarate (Tecfidera), diroximel fumarate (Vumerity), interferon beta-1a (AVONEX), peginterferon beta-1a (Plegridy), and natalizumab (Tysabri)…

History, Products, Technology & Measurement

Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.

Research this topic

Explore the main themes, entities and connections around Biogen. Start with the topic map, then use the sections below for research and deeper semantic analysis.

Explore this topic

Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

Founded
1978; 48 years ago (1978)
Founders
Kenneth Murray · Phillip Allen Sharp · Walter Gilbert · Heinz Schaller · Charles Weissmann
Industry
Biotechnology
Headquarters
Cambridge, Massachusetts, U.S.
Formerly
Biogen Idec Inc. (2003–2015)
Key people
Caroline Dorsa (chairman) · Chris Viehbacher (CEO)

Topics to explore

Browse the full topic structure. Each item opens a new analysis centered on that subject.

Overview

History

Pipeline

Lawsuits

Advanced semantic analysis

Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.

Map overview Semantic statistics

Biogen

Nodes94
Edges93
Triples117
Avg. degree1.98
Density0.021277
Components1

How this topic connects Entity context

See the strongest relationship patterns around the current topic before diving into the raw triples.

Biogen

Top relations

related to history · 39
Biogen → Acq, Announced, Apellis Pharmaceuticals, Biogen IDECBiogen, Biogen Inc, Biotechnology Geneva, CEO, Charles Weissmann, Chemistry, Convergence Pharmaceuticals, DNA, Edinburgh, Est, Fumapharm AG, Geneva, Gilbert, Harvard University, Heidelberg, Heinz Schaller, HI-Bio
related to 2010s · 17
Biogen → Bloomberg, CNV1014802, Convergence Pharmaceuticals, Convergence's, Dow Jones Sustainability World, Elan, Fampyra, In, In February, In January, In October, Index, Isis Pharmaceuticals, On December, Phase II, Tysabri, Under
related to 2000s · 16
Biogen → After, Biogen Idec, Biotechnology, California-based IDEC Pharmaceuticals, California-San Diego's, Following, Howard Birndorf, In, Ivor Royston, Richard Miller, Robert, Ron Levy, San Diego, Sobol, Stanford University, University
related to Aducanumab · 9
Biogen → Aducanumab, Alzheimer's, In, In December, Later, Neurimmune, Swiss, University, Zurich
Products · 6
Biogen → Avonex, Fampyra, Plegridy, Spinraza, Tecfidera, Tysabri
Founders · 5
Biogen → Charles Weissmann, Heinz Schaller, Kenneth Murray, Phillip Allen Sharp, Walter Gilbert
related to Lawsuits · 4
Biogen → Avonex, In September, Tecfidera, Tysabri
related to External links · 3
Biogen → Biogen Inc, GoogleReutersSEC, Official
Key people · 2
Biogen → Caroline Dorsa (chairman), Chris Viehbacher (CEO)
Traded as · 2
Biogen → Nasdaq: BIIB, S&P 500 component

Important terminology Word statistics

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

announced company aducanumab million drug approval treatment fda would inc billion massachusetts phase alzheimer's sclerosis tysabri eisai 2015 neurological biotechnology

Entity relationships Subject–Predicate–Object triples

SubjectPredicateObjectConfidenceSrc
BiogenFormerlyBiogen Idec Inc. (2003–2015)1.00infobox
BiogenFounded1978; 48 years ago (1978)1.00infobox
BiogenFoundersKenneth Murray1.00infobox
BiogenFoundersPhillip Allen Sharp1.00infobox
BiogenFoundersWalter Gilbert1.00infobox
BiogenFoundersHeinz Schaller1.00infobox
BiogenFoundersCharles Weissmann1.00infobox
BiogenHeadquartersCambridge, Massachusetts, U.S.1.00infobox
BiogenIndustryBiotechnology1.00infobox
BiogenKey peopleCaroline Dorsa (chairman)1.00infobox
BiogenKey peopleChris Viehbacher (CEO)1.00infobox
BiogenNet incomeUS$1.29 billion (2025)1.00infobox
BiogenNumber of employees7,500 (2025)1.00infobox
BiogenOperating incomeUS$1.86 billion (2025)1.00infobox
BiogenProductsAvonex1.00infobox
BiogenProductsFampyra1.00infobox
BiogenProductsPlegridy1.00infobox
BiogenProductsTecfidera1.00infobox
BiogenProductsTysabri1.00infobox
BiogenProductsSpinraza1.00infobox
BiogenRevenueUS$9.89 billion (2025)1.00infobox
BiogenTotal assetsUS$29.4 billion (2025)1.00infobox
BiogenTotal equityUS$18.3 billion (2025)1.00infobox
BiogenTraded asNasdaq: BIIB1.00infobox
BiogenTraded asS&P 500 component1.00infobox
BiogenTypePublic1.00infobox
BiogenWebsitebiogen.com1.00infobox

Related concept clusters Concept neighborhoods

These clusters group vocabulary that occurs around closely connected concepts in the source material.

    Connections between topic areas Semantic bridges

    Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.

    Min side: 3
    For writers, content strategists, SEOs, marketers and creators — from quick topic research to advanced semantic analysis.